Dr. Justin Ayed Ireifej, MD

Dr. Ireifej practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Ireifej's NPI, 1578121133, was assigned on May 30, 2019. Dr. Ireifej holds California license A178702.

Dr. Ireifej's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Ireifej also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Ireifej's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Ireifej to 1 more breast imaging center, 1 clinical lab, 1 dialysis center and 1 home health agency, each named with a free account. Dr. Ireifej's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ireifej practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Ireifej's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Ireifej is licensed in California.

CMS data shows 1,109 Medicare services from Dr. Ireifej across 5 procedure codes in 2024, for 488 Medicare patients. Medicare paid $101,781 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 488 Medicare patients who saw Dr. Ireifej in 2024. The largest group is 75 to 84, with 199 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ireifej's median patient age at 75, with 44% women.

In 2024, Dr. Ireifej wrote 550 Medicare Part D claims for 223 patients. 84% of them were for generic drugs. CMS names the drug for 262 of them, across 16 drugs with 11 or more claims each, at $25,539 in total drug cost. In 2023, CMS named 217 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Ireifej for performance year 2024, reported as part of a group. Dr. Ireifej accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Ireifej from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Vertex Pharmaceuticals Incorporated paid the most, $86.